3 Articles
3 Articles
Brookfield, CDPQ eye $1.4bn Antylia Scientific deal
Brookfield Asset Management’s private equity arm and Caisse de dépôt et placement du Québec (CDPQ) are in advanced discussions to acquire Antylia Scientific from private equity firm GTCR, according to a report by Bloomberg citing sources familiar with the matter. The deal, which could value the life sciences diagnostics provider at approximately $1.4bn, remains confidential, with representatives from Brookfield, CDPQ, and GTCR reportedly declini…
Brookfield: GP-led RE secondaries “compelling”
GP-led real estate secondaries strategies present a “compelling” opportunity for investors, a new report from Brookfield has found. The investment firm highlighted those strategies that have clear active return levers and are led by managers who have a demonstrated ability to generate value through operational expertise. The report noted that since the global financial crisis, […] The post Brookfield: GP-led RE secondaries “compelling” appeared …
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage